TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 222 filers reported holding TRANSMEDICS GROUP INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $100,138 | -31.2% | 1,829 | +5.5% | 0.01% | -28.6% |
| Q2 2023 | $145,537 | +28.2% | 1,733 | -5.8% | 0.01% | +40.0% |
| Q4 2022 | $113,565 | +47.9% | 1,840 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $76,802 | +32.7% | 1,840 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $57,868 | +16.7% | 1,840 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $49,570 | -68.2% | 1,840 | -77.4% | 0.00% | 0.0% |
| Q4 2021 | $156,097 | -42.1% | 8,147 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $269,584 | -15.6% | 8,147 | +5.8% | 0.00% | -20.0% |
| Q1 2021 | $319,390 | +98.0% | 7,698 | -5.0% | 0.01% | +150.0% |
| Q4 2020 | $161,290 | +44.4% | 8,105 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $111,687 | +4.0% | 8,105 | +35.2% | 0.00% | 0.0% |
| Q2 2020 | $107,430 | +68.6% | 5,995 | +13.6% | 0.00% | +100.0% |
| Q1 2020 | $63,722 | -36.5% | 5,275 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $100,278 | – | 5,275 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Divisadero Street Capital Management, LP | 325,000 | $27,293,500 | 7.89% |
| Ophir Asset Management Pty Ltd | 418,366 | $35,134,377 | 7.32% |
| Sandhill Capital Partners LLC | 812,844 | $68,262,667 | 6.22% |
| Kent Lake Capital LLC | 119,129 | $10,004,453 | 4.60% |
| Eagle Health Investments LP | 232,032 | $19,486,047 | 3.64% |
| NEXT CENTURY GROWTH INVESTORS LLC | 442,942 | $37,198,269 | 3.58% |
| Bullseye Asset Management LLC | 83,012 | $6,971 | 3.50% |
| First Light Asset Management, LLC | 377,464 | $31,699,427 | 2.48% |
| Nicholas Investment Partners, LP | 367,631 | $30,873,651 | 2.11% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 671,716 | $56,410,710 | 2.09% |